BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38238171)

  • 1. Protocol of the development of a core outcome set for stroke in multidimensional value assessment of traditional Chinese medicine.
    Yuan J; Yang L; Li M; Bai J; Cheng Y; Feng Y; Zhao J; Lu K
    BMJ Open; 2024 Jan; 14(1):e079492. PubMed ID: 38238171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.
    Zhang M; Chua HZ; Zhang J; Niu B; Zheng W; Li K; Zhang B
    BMJ Open; 2021 Jul; 11(7):e047148. PubMed ID: 34215606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a core outcome set on Traditional Chinese Medicine and
    Sheng X; Chen C; Ji Z; Hu H; Zhang M; Wang H; Pang B; Zhai J; Zhang D; Zhang J; Guo L
    BMJ Open; 2022 Nov; 12(11):e062497. PubMed ID: 36368756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a core outcome set for hypertensive intracerebral hemorrhage in clinical trials of traditional Chinese medicine: a study protocol.
    Jia M; Lu Y; Liang X; Tong C; Wang J; Tang J; Yang J; Wang M; Jiao W; Du W; Wei J; Zeng Z; Xu Z; Chen Q; Lei L; Liao X; Zhang Y
    Trials; 2022 Oct; 23(1):871. PubMed ID: 36224599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol.
    Qiu R; Zhong C; Han S; He T; Huang Y; Guan M; Hu J; Li M; Lin Y; Chen J; Shang H
    BMJ Open; 2019 Dec; 9(12):e032256. PubMed ID: 31796484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Core Outcome Set in the Clinical Trials of Traditional Chinese Medicine for Stroke: A Study Protocol.
    Zhang T; Li X; Zhao L; Zhang J; Tian J; Zhang J
    Front Med (Lausanne); 2022; 9():753138. PubMed ID: 35308498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjogren's syndrome in clinical trials of traditional Chinese medicine: protocol for the development of a core outcome set.
    Liu M; Gao Y; Yuan Y; Shi S; Yang K; Shi J; Wu J; Zhang J; Tian J
    Trials; 2021 Mar; 22(1):233. PubMed ID: 33771203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and safety of Chinese medicines for the treatment of uveitis: A protocol for systematic review and meta-analysis.
    Han M; Chen Y; Nong L; Liu Z; Qin Y; Meng H; Chen Y; Wang Z; Jin M
    Medicine (Baltimore); 2020 Jun; 99(26):e20766. PubMed ID: 32590753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol to develop a core outcome set for thyroid dysfunction to bridge the unmet needs of patient-centred care.
    Ooi CP; Yusof Khan AHK; Abdul Manaf R; Mustafa N; Sukor N; Williamson PR; Kamaruddin NA
    BMJ Open; 2021 Jul; 11(7):e050231. PubMed ID: 34321306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the development of a core outcome set for studies on centralisation of healthcare services.
    Pfisterer-Heise S; Scharfe J; Kugler CM; Shehu E; Wolf T; Mathes T; Pieper D
    BMJ Open; 2023 Mar; 13(3):e068138. PubMed ID: 36944460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for the development of a core outcome set for stillbirth care research (iCHOOSE Study).
    Bakhbakhi D; Fraser A; Siasakos D; Hinton L; Davies A; Merriel A; Duffy JMN; Redshaw M; Lynch M; Timlin L; Flenady V; Heazell AE; Downe S; Slade P; Brookes S; Wojcieszek A; Murphy M; de Oliveira Salgado H; Pollock D; Aggarwal N; Attachie I; Leisher S; Kihusa W; Mulley K; Wimmer L; ; Burden C
    BMJ Open; 2022 Feb; 12(2):e056629. PubMed ID: 35140161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey.
    Li G; Zhou L; Ouyang W; Xuan M; Lu L; Li X; Wen Z; Chen X
    Trials; 2019 Jan; 20(1):14. PubMed ID: 30612586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for development of a core outcome set for clinical trials in melasma.
    Ibrahim SA; Kang BY; Schlessinger DI; Chiren SG; Tang JC; Kirkham JJ; Schmitt J; Poon E; Maher IA; Sobanko JF; Cartee TV; Alam M
    BMJ Open; 2022 Feb; 12(2):e046953. PubMed ID: 35121595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COS-Speech: protocol to develop a core outcome set for dysarthria after stroke for use in clinical practice and research.
    Mitchell C; Bowen A; Conroy P; Whelan BM; Wallace SJ; Dancer A; Woodward-Nutt K; Kirkham JJ
    Trials; 2023 Jan; 24(1):57. PubMed ID: 36698201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a core outcome set for cardiac rehabilitation in patients with myocardial infarction: a study protocol.
    Guan Z; Zhang X; Jin Y; Qiu R; Shang H
    BMJ Open; 2024 Jun; 14(6):e083633. PubMed ID: 38858159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine.
    Qiu RJ; Li M; Hu JY; Chen J; Shang HC
    J Integr Med; 2021 Sep; 19(5):389-394. PubMed ID: 34384714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What should be measured and reported in clinical trials for the treatment of patients with acute pancreatitis? A study protocol for establishing a core outcome set.
    Shen Y; Hu C; Li L; Chen Z; Chen W; Lin Z; Zhu P; Tan Q; Huang W; Sun X; Deng L; Xia Q
    BMJ Open; 2023 Dec; 13(12):e075859. PubMed ID: 38070929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of core outcome sets for effectiveness trials of interventions to prevent and/or treat delirium (Del-COrS): study protocol.
    Rose L; Agar M; Burry LD; Campbell N; Clarke M; Lee J; Siddiqi N; Page VJ;
    BMJ Open; 2017 Sep; 7(9):e016371. PubMed ID: 28928181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Ma C; Panaccione R; Fedorak RN; Parker CE; Khanna R; Levesque BG; Sandborn WJ; Feagan BG; Jairath V
    BMJ Open; 2017 Jun; 7(6):e016146. PubMed ID: 28601837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.